Applied DNA Sciences IncNASDAQ:APDNNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.4800
- TODAY'S CHANGE (%)0.0002 (0.0417%)
- Bid / Lots0.4601/ 5
- Ask / Lots0.4790/ 10
- Open / Previous Close0.4760 / 0.4798
- Day Range
- 52 Week Range
- Volume366,200
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | APDN |
|---|---|---|
| 09:32 ET | 15464 | 0.473 |
| 09:34 ET | 8135 | 0.47 |
| 09:36 ET | 17951 | 0.466 |
| 09:43 ET | 900 | 0.4676 |
| 09:45 ET | 100 | 0.466 |
| 09:48 ET | 4100 | 0.46 |
| 09:54 ET | 250 | 0.472515 |
| 10:01 ET | 1600 | 0.46 |
| 10:06 ET | 260 | 0.46 |
| 10:10 ET | 8042 | 0.465 |
| 10:12 ET | 522 | 0.46505 |
| 10:15 ET | 1500 | 0.46 |
| 10:19 ET | 242 | 0.46 |
| 10:26 ET | 200 | 0.463 |
| 10:32 ET | 116 | 0.462 |
| 10:33 ET | 1208 | 0.464 |
| 10:35 ET | 150 | 0.466 |
| 10:37 ET | 700 | 0.466 |
| 10:39 ET | 150 | 0.465 |
| 10:42 ET | 600 | 0.466 |
| 10:44 ET | 500 | 0.465178 |
| 10:53 ET | 1213 | 0.469 |
| 10:55 ET | 406 | 0.473 |
| 10:57 ET | 200 | 0.469 |
| 11:02 ET | 11145 | 0.462 |
| 11:04 ET | 3100 | 0.46 |
| 11:08 ET | 500 | 0.472899 |
| 11:20 ET | 160 | 0.4729 |
| 11:24 ET | 30986 | 0.46 |
| 11:26 ET | 300 | 0.471776 |
| 11:31 ET | 250 | 0.4633 |
| 11:33 ET | 1400 | 0.4715 |
| 11:38 ET | 100 | 0.4675 |
| 11:44 ET | 1400 | 0.464 |
| 11:56 ET | 2691 | 0.4658 |
| 12:00 ET | 1099 | 0.4625 |
| 12:05 ET | 560 | 0.4716 |
| 12:20 ET | 134 | 0.465801 |
| 12:21 ET | 4028 | 0.4712 |
| 12:25 ET | 317 | 0.47 |
| 12:27 ET | 4000 | 0.46 |
| 12:34 ET | 500 | 0.47 |
| 12:38 ET | 350 | 0.47 |
| 12:39 ET | 200 | 0.4667 |
| 12:43 ET | 400 | 0.4601 |
| 12:56 ET | 208 | 0.46255 |
| 01:14 ET | 1300 | 0.464 |
| 01:15 ET | 4162 | 0.463025 |
| 01:17 ET | 600 | 0.4716 |
| 01:19 ET | 300 | 0.4716 |
| 01:21 ET | 824 | 0.47115 |
| 01:24 ET | 1236 | 0.471149 |
| 01:26 ET | 550 | 0.4723 |
| 01:28 ET | 256 | 0.47 |
| 01:30 ET | 5355 | 0.4723 |
| 01:32 ET | 500 | 0.4723 |
| 01:33 ET | 3200 | 0.4641 |
| 01:35 ET | 500 | 0.4723 |
| 01:37 ET | 200 | 0.4723 |
| 01:39 ET | 619 | 0.47 |
| 01:42 ET | 200 | 0.47 |
| 01:44 ET | 975 | 0.467 |
| 01:46 ET | 300 | 0.47 |
| 01:48 ET | 581 | 0.4681 |
| 01:50 ET | 500 | 0.4723 |
| 01:51 ET | 200 | 0.4723 |
| 01:53 ET | 300 | 0.4723 |
| 01:55 ET | 300 | 0.4723 |
| 01:57 ET | 300 | 0.4723 |
| 02:00 ET | 400 | 0.4699 |
| 02:02 ET | 300 | 0.4723 |
| 02:04 ET | 300 | 0.4723 |
| 02:06 ET | 1447 | 0.473 |
| 02:08 ET | 200 | 0.473 |
| 02:09 ET | 400 | 0.473 |
| 02:11 ET | 200 | 0.473 |
| 02:13 ET | 400 | 0.473 |
| 02:15 ET | 1169 | 0.473 |
| 02:18 ET | 300 | 0.4798 |
| 02:20 ET | 300 | 0.4749 |
| 02:22 ET | 400 | 0.4749 |
| 02:24 ET | 300 | 0.4798 |
| 02:26 ET | 12798 | 0.4797 |
| 02:27 ET | 300 | 0.4727 |
| 02:29 ET | 200 | 0.4798 |
| 02:31 ET | 300 | 0.4798 |
| 02:33 ET | 600 | 0.4798 |
| 02:36 ET | 300 | 0.4749 |
| 02:38 ET | 200 | 0.4798 |
| 02:40 ET | 7354 | 0.4798 |
| 02:42 ET | 300 | 0.4798 |
| 02:44 ET | 1400 | 0.4749 |
| 02:45 ET | 300 | 0.4798 |
| 02:47 ET | 9867 | 0.47999 |
| 02:49 ET | 3300 | 0.475 |
| 02:51 ET | 19728 | 0.4849 |
| 02:56 ET | 1800 | 0.48 |
| 02:58 ET | 300 | 0.48 |
| 03:00 ET | 30900 | 0.48 |
| 03:02 ET | 8300 | 0.4801 |
| 03:03 ET | 29092 | 0.4732 |
| 03:05 ET | 400 | 0.47935 |
| 03:12 ET | 1200 | 0.48 |
| 03:14 ET | 5343 | 0.48 |
| 03:18 ET | 5400 | 0.479899 |
| 03:20 ET | 200 | 0.4799 |
| 03:21 ET | 1201 | 0.4716 |
| 03:23 ET | 1105 | 0.4719 |
| 03:25 ET | 4300 | 0.48 |
| 03:27 ET | 400 | 0.48 |
| 03:30 ET | 2095 | 0.48 |
| 03:32 ET | 300 | 0.4758 |
| 03:34 ET | 3300 | 0.4758 |
| 03:36 ET | 500 | 0.48 |
| 03:38 ET | 200 | 0.4833 |
| 03:39 ET | 14749 | 0.487 |
| 03:41 ET | 658 | 0.489 |
| 03:43 ET | 2200 | 0.487 |
| 03:45 ET | 100 | 0.48515 |
| 03:48 ET | 399 | 0.4852 |
| 03:50 ET | 8049 | 0.4823 |
| 03:54 ET | 200 | 0.4823 |
| 03:57 ET | 1350 | 0.4824 |
| 03:59 ET | 3900 | 0.48 |
Yesterday
Jun 18, 2024
Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing, from 9:04AM ET on Tuesday Jun 18, 2024 by Dow Jones
9:04AM ET on Tuesday Jun 18, 2024 by Dow Jones
Jun 13, 2024
Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health, from 9:25AM ET on Thursday Jun 13, 2024 by Dow Jones
9:25AM ET on Thursday Jun 13, 2024 by Dow Jones
Jun 10, 2024
DJ Applied DNA Sciences Is Maintained at Buy by HC Wainwright & Co., from 7:56AM ET on Monday Jun 10, 2024 by Dow Jones
7:56AM ET on Monday Jun 10, 2024 by Dow Jones
Jun 5, 2024
Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea(TM) IVT Platform, from 9:03AM ET on Wednesday Jun 05, 2024 by Dow Jones
9:03AM ET on Wednesday Jun 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Applied DNA Sciences Inc | 4.9M | 0.0x | --- |
DermTech Inc | 4.1M | 0.0x | --- |
Vivos Therapeutics Inc | 7.7M | -0.2x | --- |
Fuse Medical Inc | 5.5M | 1.4x | +2.06% |
Scientific Industries Inc | 9.5M | -1.1x | --- |
Encision Inc | 4.2M | -9.4x | --- |
Company Information
Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes. It also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies.
Contact Information
- Headquarters
- 50 Health Sciences DriveSTONY BROOK, NY, United States 11790
- Phone
- 631-240-8800
- Fax
- 631-240-8900
Executives
- Chairman of the Board, President, Chief Executive Officer
- James Hayward
- Chief Financial Officer
- Beth Jantzen
- Chief Operating Officer, Chief Information Officer, Secretary
- Judith Murrah
- Chief Legal Officer, Executive Director - Business Development
- Clay Shorrock
- Independent Director
- Robert Catell
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.9M |
|---|---|
Revenue (TTM) | $5.5M |
Shares Outstanding | 10.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.09 |
EPS | $-17.13 |
Book Value | $7.25 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -261.64% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
